Dr. Jalal Ahmed recently published his LCRF-funded work on CAR T-cell therapy in #LungCancer. LCRF's Chief Scientific Officer, Dr. Antoinette Wozniak, explains the science of CAR T-cells and how this type of therapy can impact patient outcomes. LCRF.org/sms2664
The good news Jalal Ahmed MD, PhD, an Assistant Professor at the Precision Immunology Institute, Department of Radiation Oncology, Icahn School of Medicine, Mount Sinai in New York City, has […]
